DemensiaKITA Mobile Health App to Improve Knowledge, Attitude, Practice and Reduce Burden Among Dementia Caregivers in Malaysia

ConditionDementia
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorUniversiti Teknologi Mara

About this trial

Dementia is a growing health concern in Malaysia and places a heavy burden on family members who act as caregivers. Many caregivers struggle with limited knowledge, negative attitudes, and challenges in daily caregiving practices. These issues increase caregiver stress and reduce the quality of care for people living with dementia.

The DemensiaKITA mobile health application was developed to support caregivers by providing educational content, self-help tools, and practical guidance. This study will evaluate whether using the DemensiaKITA app can improve caregivers' knowledge, attitudes, and caregiving practices (KAP), as well as reduce caregiver burden.

This is a non-randomized controlled trial involving dementia caregivers in Kuala Lumpur and Selangor. Participants in the intervention group will use the DemensiaKITA mobile app for a set period, while the control group will continue with usual support. Outcomes will be measured before and after the intervention using validated questionnaires.

The results of this study will provide evidence on the effectiveness of a locally developed mobile health application in supporting dementia caregivers in Malaysia. If successful, this digital approach may be scaled up to improve caregiver support and dementia care in other settings.

Eligibility criteria

Qualifiers

Adults aged 18 years and above

Primary informal caregiver of a person living with dementia (family member or household member)

Able to read and understand Malay

Owns a smartphone and is able to use mobile applications

Disqualifiers

Professional/paid caregivers (e.g., nurses, domestic helpers hired solely for caregiving)

Caregivers of patients with conditions other than dementia

Individuals with severe cognitive or psychiatric illness that limits their ability to participate

Trial design

Treatments tested in this trial

  • DemensiaKITA mobile health application
  • Usual Care

Treatment groups

451 Participants
are divided into 2 treatment groups

Sponsors and collaborators